Optimizing antiepileptic treatment

Journal of Clinical Outcomes Management

Volumn 16, Issue 10, 2009, Pages 468-480

  Parkerson, Kimberly A ^a   Pathmanathan, Jay S ^a   Milligan, Tracey A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BANZEL; CARBAMAZEPINE; CLARITHROMYCIN; CLONAZEPAM; CYCLOSPORIN; DILTIAZEM; ERYTHROMYCIN; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; FLUOXETINE; GABAPENTIN; GABARONE; GABATRIL; HARKOSERIDE; ISONIAZID; LAMOTRIGINE; NEUROLEPTIC AGENT; OMEPRAZOLE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; RUFINAMIDE; STAVZOR; THEOPHYLLINE; TIAGABINE; TOPIRAMATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID; VERAPAMIL; ZONISAMIDE;

ABDOMINAL DISEASE; ABNORMAL BEHAVIOR; ABNORMAL THINKING; ABSENCE; ACUTE INTERMITTENT PORPHYRIA; ACUTE KIDNEY FAILURE; ADVERSE OUTCOME; AGRANULOCYTOSIS; ALOPECIA; ANGIONEUROTIC EDEMA; ANHIDROSIS; ANOREXIA; APLASTIC ANEMIA; ASTHENIA; ATAXIA; ATONIC SEIZURE; ATRIOVENTRICULAR BLOCK; BIPOLAR DISORDER; BLURRED VISION; BONE; BRAIN DISEASE; BULLOUS SKIN DISEASE; CEREBELLUM ATROPHY; CHRONIC DISEASE; CLEFT FACE; CLEFT PALATE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COMA; CONFUSION; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CONGESTIVE HEART FAILURE; CONSTIPATION; COST; COST EFFECTIVENESS ANALYSIS; COUGHING; DECISION MAKING; DECREASED APPETITE; DIABETIC NEUROPATHY; DILANTIN FACIES; DIPLOPIA; DISEASE CONTROL; DISSEMINATED INTRAVASCULAR CLOTTING; DIZZINESS; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG EXCRETION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DYSARTHRIA; DYSMENORRHEA; ECZEMA; EPILEPSY; EPILEPTIC STATE; EUPHORIA; EVENING DOSAGE; FACE DISORDER; FATIGUE; FIBROMYALGIA; FOCAL EPILEPSY; GENERALIZED EPILEPSY; GINGIVA HYPERPLASIA; GRAND MAL EPILEPSY; HEADACHE; HEALTH; HEART PALPITATION; HEPATITIS; HICCUP; HIRSUTISM; HUMAN; HYPERACTIVITY; HYPERAMMONEMIA; HYPERTENSION; HYPERTHERMIA; HYPOCALCEMIA; HYPONATREMIA; HYPOSPADIAS; HYPOTENSION; INCREASED APPETITE; INSOMNIA; IRRITABILITY; KIDNEY FAILURE; LENNOX GASTAUT SYNDROME; LETHARGY; LEUKOPENIA; LIVER FAILURE; LUPUS ERYTHEMATOSUS; MANIA; MEGALOBLASTIC ANEMIA; MEMORY DISORDER; METABOLIC ACIDOSIS; MIGRAINE; MONOTHERAPY; MOTOR DYSFUNCTION; MYALGIA; MYOCLONUS; MYOCLONUS EPILEPSY; NAUSEA AND VOMITING; NEPHROLITHIASIS; NEURAL TUBE DEFECT; NYSTAGMUS; OPEN ANGLE GLAUCOMA; OSTEOPENIA; OSTEOPOROSIS; OTOTOXICITY; PANCREATITIS; PANCYTOPENIA; PANIC; PARESTHESIA; PERIPHERAL EDEMA; PERIPHERAL NEUROPATHY; PHARYNGITIS; PHOTOSENSITIVITY; POSTHERPETIC NEURALGIA; PRURITUS; PSYCHOMOTOR PERFORMANCE; PURPURA; QT INTERVAL; QUALITY OF LIFE; RASH; REMISSION; RESPIRATION DEPRESSION; RESPIRATORY TRACT DISEASE; REVIEW; RICKETS; RISK; SALIVATION; SCHIZOPHRENIFORM DISORDER; SEIZURE; SIDE EFFECT; SOMNOLENCE; STEVENS JOHNSON SYNDROME; SUDDEN DEATH; SUICIDAL BEHAVIOR; SYNCOPE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOPHLEBITIS; TONIC CLONIC SEIZURE; TOXIC EPIDERMAL NECROLYSIS; TREMOR; TRIGEMINUS NEURALGIA; URINARY TRACT INFECTION; VERTIGO; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

EID: 71049172528     PISSN: 10796533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Sander JW. The epidemiology of epilepsy revisited. Curr Opin Neurol 2003;16:165-170
2. About epilepsy. Epilepsy Foundation of America. Accessed 8 Jul 2009 at www.epilepsyfoundation.org/about.
3. A guide to disability rights laws. U.S. Department of Justice, 2005 Sept. Accessed 8 Jul 2009 at www.ada.gov/cguide.pdf.
4. Berg AT, Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology 1991;41:965-972
5. Marson A, Jacoby A, Johnson A, et al. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomized controlled trial. Lancet 2005;365:2007-2013 (Pubitemid 40805008)
6. Kim LG, Johnson TL, Marson AG, et al. Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial. Lancet Neurol 2006;5:317-322
7. Bancaud J, Henriksen O, Rubio-Donnadieu F, et al. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501. (Pubitemid 11013275)
8. Dreifuss FE, Martinez-Lage M, Roger J, et al. Proposal for classification of epilepsies and epileptic syndromes. Epilepsia 1985;26:268-278 (Pubitemid 15001196)
9. Roger J, Dreifuss FE, Martinez-Lage M, et al. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399 (Pubitemid 19194714)
10. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004;62:1252-1260 (Pubitemid 38526035)
11. Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985;313:145-151
12. Mattson RH, Cramer JA, Collins JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No.264 Group. N Engl J Med 1992;327:765-771
13. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomized controlled trial. Lancet 2007;369:1000-1015 (Pubitemid 46436124)
14. Smith CT, Marson AG, Tudur Chadwick DW, Williamson PR. Multiple treatment comparisons in epilepsy monotherapy trials. Trials 2007;8:34.
15. Brodie MJ, Perucca E, Ryvlin P, et al. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 2007;68:402-408 (Pubitemid 46208740)
16. Marson, AG, Williamson PR, Clough H, et al. Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis. Epilepsia 2002;43:505-513 (Pubitemid 34533706)
17. Perucca E, Gram L, Avanzini G, Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 1998;39:5-17. (Pubitemid 28116836)
18. Genton P, Gelisse P, Thomas P, Dravet C. Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy? Neurology 2000;55:1106-1109 (Pubitemid 30802987)
19. Marson, AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalized and unclassifiable epilepsy: an unblinded randomized controlled trial. Lancet 2007;369:1016-1026 (Pubitemid 46436125)
20. Posner EB, Mohamed K, Marson AG, et al. Ethosuximide, sodium valproate, or lamotrigine for absence seizures in children and adolescents. Cochrane Database Syst Rev 2005;4:CD003032.
21. Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989;261:3273-3277
22. Montouris GD, Jagoda AS. Management of breakthrough seizures in the emergency department: continuity of patient care. Curr Med Res Opin 2007;23:1583-1592
23. Harden CL, Meador KJ, Pennell PB, et al. Practice parameter update: management issues for women with epilepsy - focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes. Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009 Apr 27 [Epub ahead of print].
24. Harden CL, Pennell PB, Koppel BS, et al. Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding. Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009 Apr 27 [Epub ahead of print].
25. Pack AM, Morrell MJ, Randall A, et al. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology 2008;70:1586-1593 (Pubitemid 351620313)
26. Ramsay RE, Rowan AJ, Pryor FM. Special considerations in treating the elderly patient with epilepsy. Neurology 2004;62:S24-9.
27. Sander JWA. National general practice study of epilepsy: newly diagnosed epileptic seizures in a general population. Lancet 1990;336:1267-1271
28. Rowen AJ. Seizure. Fundamentals of drug management of epilepsy in the older patient. Geriatrics 2002;57:33-37
29. Lackner TE, Cloyd JC, Thomas LW, Leppik IE. Antiepileptic drug use in nursing home residents: effect of age, gender, and comedication on patterns of use. Epilepsia 1998;39:1083-1087
30. Birnbaum A, Hardie NA, Leppik IE. Variability of total phenytoin serum concentrations within elderly nursing home residents. Neurology 2003;60:555-559 (Pubitemid 36246068)
31. Perucca E. Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age. Clin Pharmacokinet 2006;45:351-363
32. Ferrendelli JA, French J, Leppik I, et al. Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trial. Epilepsy Behav 2003;4:702-709 (Pubitemid 38035693)
33. Ramsay RE, Rowan AJ, Pryor FM. Special considerations in treating the elderly patient with epilepsy. Neurology 2004;62(5 Suppl 2):S24-9.
34. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-319
35. Kwan P, Brodie MJ. Effectiveness of first antiepileptic drug. Epilepsia 2001;42:1255-1260
36. Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol 2005;61:246-55.
37. Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol 2003;2:347-56.
38. Patsalos PN, Berry DJ, Bourgeois BFD, et al. Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the Subcommission on Therapeutic Drug Monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008;49:1239-79.
39. Cramer JA. Quality of life as an outcome measure for epilepsy clinical trials. Pharm World Sci 1997;19(5):227-30.
40. Drane DL, Meador KJ. Cognitive and behavioral effects of antiepileptic drugs. Epilepsy Behav 2002;3(5 Suppl):49-53.
41. Selai C, Bannister D, Trimble M. Antiepileptic drugs and the regulation of mood and quality of life (QOL): the evidence from epilepsy. Epilepsia 2005;46(Suppl 4):50-7.
42. Gillham R, Kane G, Bryant-Comstock L, Brodie MJ. A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure. Seizure 2000;9:375-9.
43. Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet 1995;345:476-9.
44. Bautista RE, Glen ET, Wludyka PS, Shetty NK. Factors associated with utilization of healthcare resources among epilepsy patients. Epilepsy Res 2008;79:120-9.
45. Cramer JA, Perrine K, Devinsky O, Meador K. A brief questionnaire to screen for quality of life in epilepsy: the QOLIE-10. Epilepsia 1996;37:577-82.
46. Johnson EK, Jones JE, Seidenberg M, Hermann BP. The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia 2004;45:544-50.
47. Fisher RS. Epilepsy from the patient's perspective: review of results of a community-based survey. Epilepsy Behav 2000;1:S9-14.
48. Gloag D. Epilepsy and employment. Br Med J (Clin Res Ed) 1985;291:2, 3.
49. Hicks RA, Hicks MJ. Attitudes of major employers toward the employment of people with epilepsy: a 30-year study. Epilepsia 1991;32:86-8.
50. Collings JA. Epilepsy and well-being. Soc Sci Med 1990;31:165-70.
51. Chaplin JE, Wester A, Tomson T. Factors associated with the employment problems of people with established epilepsy. Seizure 1998;7:299-303.
52. Clarke BM, Upton AR, Castellanos C. Work beliefs and work status in epilepsy. Epilepsy Behav 2006;9:119-25.
53. Employment. Epilepsia 2003;44(Suppl 6):49-50.
54. Diiorio C, Shafer PO, Letz R, et al. Behavioral, social, and affective factors associated with self-efficacy for self-management among people with epilepsy. Epilepsy Behav 2006;9:158-63.
55. Bautista RE, Glen ET, Shetty NK. Factors associated with satisfaction with care among patients with epilepsy. Epilepsy Behav 2007;11:518-24.